NPTX — Neuropathix Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.03m
- $1.84m
- $0.18m
Annual cashflow statement for Neuropathix, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.022 | 0.931 | -3.45 | -4.54 | -3.56 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | — | -2.79 | 1.33 | 2.97 | 1.92 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.001 | -0.125 | 0.219 | 0.602 | 0.728 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -0.023 | -1.21 | -1.89 | -0.944 | -0.89 |
| Capital Expenditures | — | -0.003 | -0.042 | 0 | -0.007 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | 0.828 | 1.61 | 0 | — |
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | — | 0.825 | 1.57 | 0 | -0.007 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.025 | 0.689 | 0.141 | 0.845 | 0.89 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.002 | 0.303 | -0.186 | -0.1 | -0.006 |